Oncology

Eur Rev Med Pharmacol Sci 2019; 23 (19): 8411-8421
DOI: 10.26355/eurrev_201910_19152

MicroRNA-381 inhibits lung adenocarcinoma cell biological progression by directly targeting LMO3 through regulation of the PI3K/Akt signaling pathway and epithelial-to-mesenchymal transition

Y.-W. Xuan, M. Liao, W.-L. Zhai, L.-J. Peng, Y. Tang
Free PDF Download

Eur Rev Med Pharmacol Sci 2019; 23 (19): 8403-8410
DOI: 10.26355/eurrev_201910_19151

LncRNA NEAT1/miR-1224/KLF3 contributes to cell proliferation, apoptosis and invasion in lung cancer

P.-F. Yu, Y. Wang, W. Lv, D. Kou, H.-L. Hu, S.-S. Guo, Y.-J. Zhao
Free PDF Download

Eur Rev Med Pharmacol Sci 2019; 23 (19): 8391-8402
DOI: 10.26355/eurrev_201910_19150

Downregulation of long non-coding RNA XIST inhibits cell proliferation, migration, invasion and EMT by regulating miR-212-3p/CBLL1 axis in non-small cell lung cancer cells

H.-B. Qiu, K. Yang, H.-Y. Yu, M. Liu
Free PDF Download

Eur Rev Med Pharmacol Sci 2019; 23 (19): 8377-8390
DOI: 10.26355/eurrev_201910_19149

LINC00511 promotes the progression of non-small cell lung cancer through downregulating LATS2 and KLF2 by binding to EZH2 and LSD1

F.-Y. Zhu, S.-R. Zhang, L.-H. Wang, W.-D. Wu, H. Zhao
Free PDF Download

Eur Rev Med Pharmacol Sci 2019; 23 (19): 8371-8376
DOI: 10.26355/eurrev_201910_19148

The carcinogenic complex lncRNA FOXP4-AS1/EZH2/LSD1 accelerates proliferation, migration and invasion of gastric cancer

R.-Y. Chen, Q. Ju, L.-M. Feng, Q. Yuan, L. Zhang
Free PDF Download

Eur Rev Med Pharmacol Sci 2019; 23 (19): 8360-8370
DOI: 10.26355/eurrev_201910_19147

STAT5A reprograms fatty acid metabolism and promotes tumorigenesis of gastric cancer cells

S.-R. Dong, X.-L. Ju, W.-Z. Yang
Free PDF Download

Eur Rev Med Pharmacol Sci 2019; 23 (19): 8354-8359
DOI: 10.26355/eurrev_201910_19146

Endoscopic submucosal dissection for superficial premalignant and malignant epithelial neoplasms of the digestive tract: a real-life experience in Italy

N. Pagano, L. Frazzoni, M. La Porta, L. Fuccio, F. Bazzoli, R.M. Zagari
Free PDF Download

Eur Rev Med Pharmacol Sci 2019; 23 (19): 8345-8353
DOI: 10.26355/eurrev_201910_19145

Reduced serum miR-98 predicts unfavorable clinical outcome of colorectal cancer

Y.-G. Wang, Q. He, S.-Q. Guo, Z.-Z. Shi
Free PDF Download

Eur Rev Med Pharmacol Sci 2019; 23 (19): 8332-8344
DOI: 10.26355/eurrev_201910_19144

MiR-372-3p promotes tumor progression by targeting LATS2 in colorectal cancer

H. Peng, X. Pan, Q. Su, L.-S. Zhu, G.-D. Ma
Free PDF Download

Eur Rev Med Pharmacol Sci 2019; 23 (19): 8321-8331
DOI: 10.26355/eurrev_201910_19143

The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway

J.-J. Zhang, W.-R. Xu, B. Chen, Y.-Y. Wang, N. Yang, L.-J. Wang, Y.-L. Zhang
Free PDF Download

Eur Rev Med Pharmacol Sci 2019; 23 (19): 8310-8320
DOI: 10.26355/eurrev_201910_19142

LncRNA PCAT-1 regulated cell proliferation, invasion, migration and apoptosis in colorectal cancer through targeting miR-149-5p

A.-H. Wang, W.-J. Fan, L. Fu, X.-T. Wang
Free PDF Download

Eur Rev Med Pharmacol Sci 2019; 23 (19): 8303-8309
DOI: 10.26355/eurrev_201910_19141

LncRNA CASC15 promotes migration and invasion in prostate cancer via targeting miR-200a-3p

C. Zhang, G.-X. Wang, B. Fu, X.-C. Zhou, Y. Li, Y.-Y. Li
Free PDF Download

Eur Rev Med Pharmacol Sci 2019; 23 (19): 8295-8302
DOI: 10.26355/eurrev_201910_19140

High-expression of lncRNA CEBPA-AS1 promotes liver cancer progression

C. Wu, Z.-Y. Tang, H.-Y. Chen, J. Zhang, C. Zhao
Free PDF Download

Eur Rev Med Pharmacol Sci 2019; 23 (19): 8287-8294
DOI: 10.26355/eurrev_201910_19139

LncRNA RUNX1-IT1 inhibits proliferation and promotes apoptosis of hepatocellular carcinoma by regulating MAPK pathways

P.-H. Yan, L. Wang, H. Chen, F.-Q. Yu, L. Guo, Y. Liu, W.-J. Zhang, Y.-L. Bai
Free PDF Download

Eur Rev Med Pharmacol Sci 2019; 23 (19): 8274-8286
DOI: 10.26355/eurrev_201910_19138

Characterization of hsa_circ_0000594 as a new biomarker and therapeutic target for hepatoblastoma

H. Song, Z.-X. Bian, H.-Y. Li, Y. Zhang, J. Ma, S.-H. Chen, J.-B. Zhu, X. Zhang, J. Wang, S. Gu, M. Xu, Q.-H. Pan, M.-Z. Yin, L. Zheng
Free PDF Download

Eur Rev Med Pharmacol Sci 2019; 23 (19): 8265-8273
DOI: 10.26355/eurrev_201910_19137

FBXO17 promotes malignant progression of hepatocellular carcinoma by activating wnt/β-catenin pathway

F.-H. Liu, Y.-P. Cui, Y.-K. He, R.-H. Shu
Free PDF Download

Eur Rev Med Pharmacol Sci 2019; 23 (19): 8257-8264
DOI: 10.26355/eurrev_201910_19136

A comprehensive understanding of ovarian carcinoma survival prognosis by novel biomarkers

Y. Wang, L. Lei, Y.-G. Chi, L.-B. Liu, B.-P. Yang
Free PDF Download

Eur Rev Med Pharmacol Sci 2019; 23 (19): 8249-8256
DOI: 10.26355/eurrev_201910_19134

MiR-125a-5p inhibits EMT of ovarian cancer cells by regulating TAZ/EGFR signaling pathway

Y. Cao, T. Shen , C. Zhang, Q.-H. Zhang, Z.-Q. Zhang
Free PDF Download

Eur Rev Med Pharmacol Sci 2019; 23 (19): 8239-8248
DOI: 10.26355/eurrev_201910_19133

PCAT1 promotes the proliferative and migratory potentials of ovarian cancer via targeting NEK2

X.-L. Liu, H.-M. Liu, N. Han, F.-H. Li, F. Sun, D.-M. Fan, Q. Xu
Free PDF Download

Eur Rev Med Pharmacol Sci 2019; 23 (19): 8230-8238
DOI: 10.26355/eurrev_201910_19132

LncRNA PCAT6 promotes occurrence and development of ovarian cancer by inhibiting PTEN

F.-R. Kong, Y.-H. Lv, H.-M. Yao, H.-Y. Zhang, Y. Zhou, S.-E. Liu
Free PDF Download